Retractable TechnologiesRVP -3.15%35 3-Year ROIIC % is 44.87 as of Dec. 2025, which is 4% below its 10-year median of 46.93. GuruFocus rates RVP with a GF Score™ of 35/100 and a GF Value™ of $0.77 (Fairly Valued). The stock has 3 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Retractable Technologies ranks better than 81.98% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Retractable Technologies's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 44.87%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Retractable Technologies's 3-Year ROIIC % or its related term are showing as below:
RVP's 3-Year ROIIC % is ranked better than 81.98% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.67
vs RVP: 44.87
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Retractable Technologies 3-Year ROIIC % Related Terms
Retractable Technologies 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RVP vs ZJYL, HBIO, RGNT: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Retractable Technologies's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Retractable Technologies 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Retractable Technologies's 3-Year ROIIC % falls into.
Retractable Technologies's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -14.269 (Dec. 2025) - 2.931426 (Dec. 2022) )
/
( 97.541 (Dec. 2025) - 135.871 (Dec. 2022) )
=
-17.200426
/
-38.33
=
44.87%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Retractable Technologies (RVP) has a 3-Year ROIIC % of 44.87 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Retractable Technologies and its competitors. This is near median its historical median of 46.93. According to the industry distribution chart, Retractable Technologies ranks #144 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 18%.
Is Retractable Technologies' 3-Year ROIIC % too high?
Retractable Technologies' current 3-Year ROIIC % of 44.87 is near median its 10-year median of 46.93. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.67. Retractable Technologies' value of 44.87 is 2586.8% above this industry median. Based on the distribution chart, Retractable Technologies ranks #144 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Retractable Technologies has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Retractable Technologies' 3-Year ROIIC % compare to ZJYL and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Retractable Technologies ranks #144 out of 799 companies for 3-Year ROIIC %. This places Retractable Technologies in the top 18% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.67. Retractable Technologies' value of 44.87 is 2586.8% above this benchmark. While the company's 10-year median is 46.93 vs. the industry median of 1.67, Retractable Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.67, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Retractable Technologies's current 3-Year ROIIC % of 44.87 is 2586.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Retractable Technologies and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Retractable Technologies's current 3-Year ROIIC % is 44.87, which is near median its own 10-year median of 46.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Retractable Technologies stock overvalued right now?
Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Fairly Valued. The stock's GF Value™ is $0.77, compared to a current price of $0.71 — trading 7.7% below its estimated fair value. The current 3-Year ROIIC % is 44.87, which is near median its 10-year median of 46.93 and 2586.8% above the Medical Devices & Instruments industry median of 1.67. Retractable Technologies' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Retractable Technologies (RVP), the current 3-Year ROIIC % is 44.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Retractable Technologies (RVP) Overvalued in 2026?
Based on GuruFocus' analysis, Retractable Technologies stock appears to be undervalued.
The current stock price of $0.71 is trading 7.7% below its estimated GF Value™ of $0.77.
GuruFocus considers Retractable Technologies to be Fairly Valued.
Key valuation signals for RVP:
3-Year ROIIC %: 44.87 (near median its 10-year median of 46.93)
GF Value™: $0.77 vs. price of $0.71 (7.7% below fair value)
Industry Position: 2586.8% above the Medical Devices & Instruments median (#144 of 799)
No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
35GF Score
Get the complete analysis for RVP
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVP has been successfully added to your 
